Latest News

Daily Recap: Docs are good at saving money; SARS-CoV-2 vaccine trials advance


 

Could a visual tool aid migraine management?

A new visual tool aims to streamline patient-clinician communication about risk factors for progression from episodic to chronic migraines.

The tool is still just a prototype, but it could eventually synthesize patient responses to an integrated questionnaire and produce a chart illustrating where the patient stands with respect to a range of modifiable risk factors from depression to insomnia.

Physicians must see patients in short appointment periods, making it difficult to communicate all of the risk factors and behavioral characteristics that can contribute to risk of progression. “If you have a patient and you’re able to look at a visualization tool quickly and say: ‘Okay, my patient really is having insomnia and sleep issues,’ you can focus the session talking about sleep, cognitive-behavioral therapy for insomnia, and all the things we can help patients with,” lead researcher Ami Cuneo, MD, who is a headache fellow at the University of Washington, Seattle, said in an interview.

Dr. Cuneo presented a poster describing the concept at the virtual annual meeting of the American Headache Society. Read more.

For more on COVID-19, visit our Resource Center. All of our latest news is available on MDedge.com.

Pages

Recommended Reading

Guidance on infection prevention for health care personnel
MDedge Dermatology
Inside Mercy’s mission to care for non-COVID patients in Los Angeles
MDedge Dermatology
COVID-19: Medicare data show long hospital stays, disparities
MDedge Dermatology
What COVID-19 has taught us about senior care
MDedge Dermatology
Daily Recap: Higher risk of severe COVID-19 seen in pregnancy, primary care practices at risk
MDedge Dermatology
ACIP plans priority groups in advance of COVID-19 vaccine
MDedge Dermatology
How racism contributes to the effects of SARS-CoV-2
MDedge Dermatology
Daily Recap: Transgender patients turn to DIY treatments; ACIP plans priority vaccine groups
MDedge Dermatology
Skin patterns of COVID-19 vary widely
MDedge Dermatology
Phase 3 COVID-19 vaccine trials launching in July, expert says
MDedge Dermatology